NDC Package 14335-070-01 Eptifibatide

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
14335-070-01
Package Description:
10 mL in 1 VIAL
Product Code:
Proprietary Name:
Eptifibatide
Usage Information:
Treatment with eptifibatide injection is contraindicated in patients with:A history of bleeding diathesis, or evidence of active abnormal bleeding within the previous 30 days Severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >110 mm Hg) not adequately controlled on antihypertensive therapy Major surgery within the preceding 6 weeks History of stroke within 30 days or any history of hemorrhagic stroke Current or planned administration of another parenteral GP IIb/IIIa inhibitor Dependency on renal dialysis Hypersensitivity to eptifibatide injection or any component of the product (hypersensitivity reactions that occurred included anaphylaxis and urticaria).
11-Digit NDC Billing Format:
14335007001
NDC to RxNorm Crosswalk:
  • RxCUI: 1736470 - eptifibatide 20 MG in 10 ML Injection
  • RxCUI: 1736470 - 10 ML eptifibatide 2 MG/ML Injection
  • RxCUI: 1736470 - eptifibatide 20 MG per 10 ML Injection
  • RxCUI: 200349 - eptifibatide 75 MG in 100 ML Injection
  • RxCUI: 200349 - 100 ML eptifibatide 0.75 MG/ML Injection
  • Labeler Name:
    Hainan Poly Pharm. Co., Ltd.
    Sample Package:
    No
    Start Marketing Date:
    07-22-2019
    Listing Expiration Date:
    12-31-2022
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 14335-070-01?

    The NDC Packaged Code 14335-070-01 is assigned to a package of 10 ml in 1 vial of Eptifibatide, labeled by Hainan Poly Pharm. Co., Ltd.. The product's dosage form is and is administered via form.

    Is NDC 14335-070 included in the NDC Directory?

    No, Eptifibatide with product code 14335-070 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Hainan Poly Pharm. Co., Ltd. on July 22, 2019 and its listing in the NDC Directory is set to expire on December 31, 2022 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 14335-070-01?

    The 11-digit format is 14335007001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-214335-070-015-4-214335-0070-01